HYPR
Hyperfine, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.78
+1.54%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.08
- Revenue estimate
- $5.1M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.09
- EPS estimate
- -$0.09
- Revenue actual
- $3.9M
- Revenue estimate
- $4.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 4
- Avg surprise (4Q)
- +2.9%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $1.80
- PT range
- $1.60 – $2.00
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.09 | -$0.09 | In line | $3.9M |
| May 12, 2026 | -$0.09 | -$0.09 | In line | $3.9M |
| Mar 18, 2026 | -$0.08 | -$0.06 | Beat 21.55% | $5.3M |
| Nov 13, 2025 | -$0.10 | -$0.11 | Miss -10.00% | $3.4M |
| Aug 13, 2025 | -$0.12 | -$0.12 | In line | $2.7M |
| Mar 17, 2025 | -$0.16 | -$0.14 | Beat 12.50% | $2.3M |
| Mar 21, 2024 | -$0.17 | -$0.15 | Beat 11.76% | $2.7M |
| Nov 9, 2023 | -$0.15 | -$0.15 | In line | $2.3M |
| Aug 14, 2023 | -$0.17 | -$0.15 | Beat 11.76% | $3.4M |
| May 11, 2023 | -$0.16 | -$0.17 | Miss -6.25% | $2.6M |
| Mar 21, 2023 | -$0.25 | -$0.19 | Beat 24.00% | $1.4M |
| Nov 10, 2022 | -$0.26 | -$0.19 | Beat 26.92% | $2.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026